Evidence map›Paper›PMID 39979222›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Heterogeneous Fe-N-C Cocatalyst for Hydroquinone Oxidation Enables Aerobic Oxidation of Primary Alcohols to Aldehydes.

Md Asmaul Hoque, Clara Schweinzer, Jesse J Martinez, Friederike Tewes, Vittorio Sacchetti, Hansjörg Grützmacher, Shannon S Stahl

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Copper-catalyzed and Y(OTf)RSC advances · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Md Asmaul HoqueDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.ORCID https://orcid.org/0000-0003-3942-863X
Clara SchweinzerDepartment of Chemistry and Applied Biosciences, ETH, Zürich, Vladimir-Prelog-Weg 1, 8093Zürich, Switzerland.
Jesse J MartinezDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Friederike TewesDepartment of Chemistry and Applied Biosciences, ETH, Zürich, Vladimir-Prelog-Weg 1, 8093Zürich, Switzerland.
Vittorio SacchettiDepartment of Chemistry and Applied Biosciences, ETH, Zürich, Vladimir-Prelog-Weg 1, 8093Zürich, Switzerland.
Hansjörg GrützmacherDepartment of Chemistry and Applied Biosciences, ETH, Zürich, Vladimir-Prelog-Weg 1, 8093Zürich, Switzerland.ORCID https://orcid.org/0000-0002-1531-8906
Shannon S StahlDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.ORCID https://orcid.org/0000-0002-9000-7665

Funding

Catalytic Redox Reactions for Pharmaceutical SynthesisR35GM134929 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Shannon S Stahl · 2020 to 2026
$4.3M
QExactive (Orbitrap) mass spectrometerS10OD020022 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI VESTLING, MARTHA M · 2015 to 2015
$483k
Basic Energy Sciences DE-FG02-05ER15690National Science Foundation CHE-1048642NIGMS NIH HHS R35 GM134929NIH HHS S10 OD020022ODCDC CDC HHS S10 OD020022Swiss National Science Foundation 20020 181966
6 · The paper itself

Abstract

Benzoquinone (BQ) is commonly used as a cocatalyst in multi-component catalyst systems for aerobic oxidation of organic molecules. Such methods often proceed by a redox cascade in which a secondary catalyst supports aerobic oxidation of hydroquinone (HQ) to BQ. The present study shows that a commercially available non-precious metal heterogeneous catalyst, PAJ-Fe-N-C, is much more efficient than established homogeneous catalysts for aerobic oxidation of HQ to BQ, and this improved reactivity is crucial to support aerobic oxidation of primary alcohols to aldehydes with the homogeneous iridium catalyst, [Ir(trop

Indexed as

Aerobicalcohol oxidationaldehydesbenzoquinonecatalysis

Identifiers

PMID39979222
PMCPMC12070451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.